These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 2550135

  • 21. [Ednit effects on activity of renin-angiotensin-aldosterone system and renal function in hypertensive subjects with diabetes mellitus].
    Zonis BIa, Volkova NI, Sokolov OIu.
    Ter Arkh; 2000; 72(2):53-5. PubMed ID: 10717928
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Total and split renal function in patients with renovascular hypertension: effects of angiotensin-converting enzyme inhibition.
    Reams GP, Singh A, Logan KW, Holmes RA, Bauer JH.
    J Clin Hypertens; 1987 Jun; 3(2):153-63. PubMed ID: 3039075
    [Abstract] [Full Text] [Related]

  • 24. Enalapril in hypertension with renal artery stenosis: long-term follow-up and effects on renal function.
    Tillman DM, Malatino LS, Cumming AM, Hodsman GP, Leckie BJ, Lever AF, Morton JJ, Webb DJ, Robertson JI.
    J Hypertens Suppl; 1984 Dec; 2(2):S93-100. PubMed ID: 6100883
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Effect of enalapril in subjects with hypertension associated with moderate to severe renal dysfunction.
    Reams GP, Bauer JH.
    Arch Intern Med; 1986 Nov; 146(11):2145-8. PubMed ID: 3022660
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [A case of malignant hypertension in whom steroid improved renal function].
    Sasaki N, Ando Y, Ootomo T, Ishiharajima S, Kusano E, Asano Y.
    Nihon Jinzo Gakkai Shi; 1999 Dec; 41(8):818-24. PubMed ID: 10655731
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Use of the converting enzyme inhibitor enalapril in renovascular hypertension. Effect on blood pressure, renal function, and the renin-angiotensin-aldosterone system.
    Reams GP, Bauer JH, Gaddy P.
    Hypertension; 1986 Apr; 8(4):290-7. PubMed ID: 3007351
    [Abstract] [Full Text] [Related]

  • 31. An angiotensin converting-enzyme inhibitor to identify and treat vasoconstrictor and volume factors in hypertensive patients.
    Gavras H, Brunner HR, Laragh JH, Sealey JE, Gavras I, Vukovich RA.
    N Engl J Med; 1974 Oct 17; 291(16):817-21. PubMed ID: 4371298
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Reversible malignant hypertension and azotemia due to urethral stricture.
    Vincenti FG, Heymsfield S.
    Arch Intern Med; 1977 Mar 17; 137(3):370-2. PubMed ID: 843154
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [The participation of the renin-angiotensin-aldosterone system in the pathogenesis of acute kidney failure in endotoxemia].
    Krishtal' NV, Frolov AF, Kukharchuk AL.
    Lik Sprava; 1995 Mar 17; (3-4):92-4. PubMed ID: 8819932
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Renoprotective effects of renin-angiotensin-system inhibitors.
    Adler A, Stratton I, Shine B.
    Lancet; 2006 Mar 18; 367(9514):897-8; author reply 900-2. PubMed ID: 16546530
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.